NPI registry status
Active
2026 NPPES data Retina Specialist (Ophthalmology) Physician NPI 1003542101 MD, PHD
Verify on CMS → Ayman Elnahry, MD, PHD
Retina Specialist (Ophthalmology) Physician in Edmond, Oklahoma.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 983 in Retina Specialist (Ophthalmology) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
299
Medicare Part D claims · 124 beneficiaries · Retina Specialist (Ophthalmology) Physician avg: 593
Generic prescribing
66%
generic claims · 34% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$770.57
11 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Ayman Elnahry, MD, PHD filed 299 Medicare Part D claims in 2024 as a Retina Specialist (Ophthalmology) Physician in Edmond, Oklahoma, prescribing 66% generic.
- 299
- Part D claims, 2024
- 66%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥48th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Ayman Elnahry, MD, PHD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1003542101), first enumerated 07/29/2022.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 299 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
2 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$770.57 in reported industry payments (11 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1003542101 · Retina Specialist (Ophthalmology) Physician
NPI-10 · ENUM-RECENT · TAX-NARROW · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1003542101
- ENUM-RECENT 2022
- TAX-NARROW 983
- RX-LIGHT 299
- BOOK-THIN 8 in Oklahoma
- PHOTO-ENUM Itika Garg, MD · 2022
Ayman Elnahry, MD, PHD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
299 ≥ 48th percentile 48% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Ayman Elnahry, MD, PHD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Ayman Elnahry, MD, PHD?
Quality data not reportedPrimary specialty
Retina Specialist (Ophthalmology) Physician
Medicare Part D claims
299 50% vs specialty avg
Specialty distribution in Oklahoma
How Retina Specialist (Ophthalmology) Physician compares to other specialties among Oklahoma providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Retina Specialist (Ophthalmology) Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1003542101 |
|---|---|
| Specialty | Retina Specialist (Ophthalmology) Physician |
| Credentials | MD, PHD |
| Gender | Male |
| NPI Issued | 07/29/2022 |
Hospital and facility affiliations
Facilities where Ayman Elnahry, MD, PHD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Baycare Clinic LLP
Green Bay, WI
Retina Vitreous Center, PLLC
Edmond, OK
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Ayman Elnahry, MD, PHD. Source: openpaymentsdata.cms.gov.
Total received
$771
Largest payer
Regeneron Healthcare Solutions, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
Ayman Elnahry, MD, PHD - brand share 34.0%
Retina Specialist (Ophthalmology) Physician average
34% brand-name claims vs 66% generic, on 299 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
299
Total Claims
$9K
Total Drug Cost
124
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 408.467
- Total Day Supply
- 10,228
- Brand vs Generic
- 34% brand / 66% generic
- Brand Drug Cost
- $4K
- Generic Drug Cost
- $4K
Patient Demographics
- Average Patient Age
- 75.0 years
- Avg HCC Risk Score
- 1.61
- Gender Split
- 55% female / 45% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Ayman Elnahry, MD, PHD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Prednisolone Acetate
Prednisolone Acetate
73 claims
- Neomycin-Polymyxin…
Neomycin-Polymyxin-Dexameth
66 claims
- Diclofenac Sodium
Diclofenac Sodium
46 claims
- Timolol Maleate 20
Timolol Maleate
20 claims
- Moxifloxacin 16
Moxifloxacin
16 claims
- Dorzolamide-Timolol 12
Dorzolamide-Timolol
12 claims
| Drug | Claims |
|---|---|
| Prednisolone Acetate | 73 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 66 |
| Diclofenac Sodium | 46 |
| Timolol Maleate | 20 |
| Moxifloxacin Moxifloxacin Hcl | 16 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Retina Specialist (Ophthalmology) Physician in OK →
All providers in Oklahoma →
Compare specialties →
Retina Specialist (Ophthalmology) Physician Overview
How Ayman Elnahry, MD, PHD fits within the Retina Specialist (Ophthalmology) Physician landscape nationally.
983
Retina Specialist (Ophthalmology) Physician Providers in US
48
States with Retina Specialist (Ophthalmology) Physician
593
Avg Claims per Provider
Ayman Elnahry, MD, PHD's 299 claims are below the specialty average of 593.
Nationwide Retina Specialist (Ophthalmology) Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Elnahry, both outside Oklahoma so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2022)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Retina Specialist (Ophthalmology) Physician Providers in Oklahoma
Other clinicians with the same primary specialty enrolled in Oklahoma, drawn from the same CMS NPPES roster as Elnahry.
One of 8 Retina Specialist (Ophthalmology) Physician providers enrolled in Oklahoma, 5 are shown here.
Seifollah Azadi
Oklahoma City, OK
Dr. Elizabeth Fairless
MD
Oklahoma City, OK
Dr. Michael Hood
M.D.
Edmond, OK
Dr. Jordan Johnson
MD
Oklahoma City, OK
Gina Mahatma
Oklahoma City, OK
Compare Retina Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Ayman Elnahry, MD, PHD's specialty? ▼
Ayman Elnahry, MD, PHD specializes in Retina Specialist (Ophthalmology) Physician and practices in Edmond, Oklahoma. Credentials: MD, PHD.
How much does Ayman Elnahry, MD, PHD prescribe under Medicare Part D? ▼
In 2024, Ayman Elnahry, MD, PHD wrote 299 Medicare Part D claims totaling $9K in drug costs for 124 beneficiaries.
Where is Ayman Elnahry, MD, PHD located? ▼
Ayman Elnahry, MD, PHD is located at 1851 S KELLY AVE STE A, Edmond, OK, 73013. Phone: (405) 607-6699.
What is Ayman Elnahry, MD, PHD's NPI number? ▼
Ayman Elnahry, MD, PHD's National Provider Identifier (NPI) is 1003542101, issued on 07/29/2022.
Does Ayman Elnahry, MD, PHD prescribe more brand-name or generic drugs? ▼
Ayman Elnahry, MD, PHD's prescribing is 34% brand-name and 66% generic drugs by claim count, with $4K in brand drug costs.
How many Retina Specialist (Ophthalmology) Physician providers are there in the US? ▼
There are 983 Retina Specialist (Ophthalmology) Physician providers across 48 states in the US. The average Retina Specialist (Ophthalmology) Physician provider writes 593 Medicare Part D claims per year.
What drugs does Ayman Elnahry, MD, PHD prescribe most often? ▼
Based on 2024 Medicare Part D data, Ayman Elnahry, MD, PHD's most frequently prescribed drugs include Prednisolone Acetate, Neomycin-Polymyxin-Dexameth, Diclofenac Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Ayman Elnahry, MD, PHD accept Medicare? ▼
Ayman Elnahry, MD, PHD appears in CMS Medicare data with 299 Part D claims and 124 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Ayman Elnahry, MD, PHD's credentials? ▼
Ayman Elnahry, MD, PHD's NPI is 1003542101 with credentials MD, PHD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.